Krishnamani Kannan’s Post

Are you working on innovative health services research in Singapore? The Health Services Research Grant (HSRG) offers substantial funding for projects that aim to improve health services and patient outcomes. The application process involves submitting a detailed research proposal outlining your objectives, methodology, expected outcomes, and budget.  Proposals are evaluated based on scientific merit, relevance, feasibility, and potential impact. Here are some key details: -Funding Amount:  Up to SGD 1 million per project, enabling significant research advancements. -Eligibility:  Open to researchers and institutions, including public healthcare and academic institutions. -Focus Areas:  Includes studies on healthcare delivery, policy, management, and innovations in healthcare practices and systems. This is a fantastic opportunity to advance your research and make a significant impact on healthcare in Singapore. Don’t miss out on this chance to bring your innovative ideas to life Interested in applying or need more info?  Let’s connect and discuss how you can leverage this grant. Follow Krishnamani Kannan for more. #Singapore #Healthcare #Research #Management #PublicHealth #Funding

The Ministry of Health (Singapore) and the Economic Society of Singapore are extending an invitation for participation in the MOH-ESS Essay Competition. This competition aims to foster thoughtful discourse on the application of health economics to Singapore’s Healthcare System. Entries are welcome from youths aged 18 to 35 years old living in Singapore, as well as Singaporean youths living abroad. This year, the topic for the Essay Competition is "Resource Allocation in Singapore’s Healthcare System”. In Singapore, the demand for healthcare continues to grow amidst our rapidly ageing population. By contrast, the supply of healthcare resources is limited and sticky due to the time and effort needed to train healthcare professionals and build infrastructure. As such, there is increasing pressure on the government to ensure that healthcare resources are allocated fairly and efficiently across various stakeholders in Singapore. The deadline for entries is 13 August 2024. For comprehensive information, please visit www.ess.org.sg.

👋Attending today's 2024 Virtual Asia Pacific Meeting of #ISMPP? 📚 Join an expert faculty including #OxfordPharmaGenesis Communications Consultant Henry Chung to explore cultural and communications considerations for medical publications in #AsiaPacific! Medical Publication: Considerations in Asia Pacific 🕐 11:00–11:45 AM (SGT) 💡 Understand the differences in cultural and communication norms across many Asia Pacific countries that may be perceived as potential barriers to applying #GoodPublicationPractice 💡 Gain practical insights into applying ethical and transparent publication practice that embrace the diversity of cultures and communication norms within Asia Pacific, supporting a more inclusive publications environment 💡 Understand how best to navigate innovations in #MedicalPublications (e.g. #PlainLanguageSummaries, patient authorship, social media) to maintain the integrity of published research in Asia Pacific See you there! #MedComms #EthicalResearch #ISMPPAsiaPacific

Thank you Anh BOURCET, Prof. Hwee-Lin Wee, & National University of Singapore for the great opportunity! The course achieved the following pillars: 1. Navigate complex market access pathways, barriers, and opportunities 2. Develop a market access strategy, including reimbursement strategy and policy shaping 3. Develop a robust value proposition and dossier 4. Outline an evidence generation strategy, including real-world evidence (RWE) and health economics and outcomes research (HEOR) 5. Value-based healthcare, pricing & procurement, and ecosystem shaping

📣 Are you looking to enter the US market or expand your footprint? 💻 Register for Australian Trade and Investment Commission (Austrade)'s dedicated online information sessions featuring presenters from four best-in-class US healthcare organisations. 💊🩺⚕💉🏥🔬 These sessions are suitable to anyone interested in exploring the US healthcare market as an export opportunity. Each organisation will share knowledge and tips on: ✔ What kind of companies they’re excited to work with ✔ Understanding various pathways offered by these institutions and how this can enhance market strategies ✔ What an Australian exporter can expect from working together to gain traction in a highly competitive market 🟢 Session 1: February 8 @10 am AEDT featuring Cedars-Sinai Technology Ventures and Northwell Health  👉 Register for Session 1 https://lnkd.in/gvNkikE9 🟢 Session 2: February 20 @ 10 am AEDT featuring Texas Medical Center and Medical Alley Association 👉 Register for Session 2 https://lnkd.in/gRP3cthV Please TAG a colleague or client who could benefit from these sessions. Department for Industry, Innovation and Science | Chief Scientist for South Australia | Jo Close | Dana Bell | Natalie Rickers, PhD, GAICD #buildingcapacity #healthtechjobssa #globalexpansion #globalmarketstrategies #seeyouonline

Join us this July to learn from experts around the world on the latest in #clinicaltrials! 💡 Day 1 Speaker Highlights 💡 ➡️ Keynote Speakers Our keynote speakers will speak on how clinical trials is transforming healthcare delivery, such as during the COVID-19 pandemic. These presentations will be followed by an engaging panel that will explore the value proposition of clinical trials from the patient's, healthcare professionals and industry perspective. ➡️ Clinical Trials for Health Outcomes and its Impact on Healthcare Esteemed health economists will explain the key role of Healthcare Economics and Outcomes Research (HEOR) in guiding clinical trials towards the cost-efficient use of resources and examine the overall impact on population health when it comes to exploring new or novel healthcare interventions. ➡️ Patient Advocacy Groups, Community Involvement and Collaboration in Advancing Clinical Research Patient advocacy reps from the community will discuss how a deeper understanding of patient needs has potential to sharpen research relevance and accelerate the development of innovative therapies for better healthcare. 💡 Day 2 Speaker Highlights 💡 ➡️ Unveiling Diverse Clinical Trial Landscapes Across Countries Panellists will discuss the latest clinical trial developments from around the world, as well as explore ways to improve collaboration across borders to advance clinical research. ➡️ Challenges and Opportunities for Biotechs to Conduct Clinical Trials in Singapore Panellists will explore the unique challenges and opportunities in conducting clinical trials in Singapore. From regulatory considerations to infrastructure development and funding, hear from speakers on how they are navigating the local clinical trial landscape. ➡️ Innovations in Data-Driven Research: Shaping Tomorrow's Discoveries In this digital age, our panel speakers will uncover how data-driven research, with stringent data governance in place, is driving innovation and shaping future discoveries. 🙋♂️ 🙋♀️ Sign-up for this conference to learn from the best and keep the conversations going at this excellent opportunity for knowledge exchange and networking. 🗓️ 30 to 31 July 2024 📍 Raffles City Convention Centre 📣 🐥 Early bird tickets available until 31 May 2024. 👉 Register now at https://for.sg/symposiumli Swipe through to find out more about the discussions in store for Day 1 and Day 2! For more information, visit https://for.sg/symposiumli #SCRIClinicalTrialsSymposium2024 #TransformingTomorrowsHealth #ClinicalTrials

The effect of NHI on private healthcare companies in South Africa. Who will it affect, how will it affect them and will it realise its goals?! 😶🌫️ In 2019, I was fortunate enough to do a research paper based on the topic that will now seemingly test my conclusions in reality... This paper was without a doubt one of the most intellectually stimulating experiences of my University career. PS. THIS IS MERELY AN INTERESTING FACT and the first time my University Theory will be "tested/applied" in Practice.🤔 #SouthAfrica #Healthcare #Learning

𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗳 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 African countries are making continuous investments in research infrastructure and implementing robust regulatory frameworks, thereby making the continent an increasingly attractive center for clinical trials and medical research. Clinical research in Africa has the potential to provide valuable insights into global healthcare and improve healthcare services across the continent. With careful consideration of ethical, infrastructural, and financial challenges, it holds a chance to enhance the health outcomes of the population and benefit the global medical community. #clinicaltrials #clinicalresearch  #clinicaltrial  #clinicalstudies  #clinicaloperations  #globalhealth  #InSiGHtHealthClinical

Grateful to be working alongside a team passionate about clinical trial access in Singapore - Atul Chaudhari, Luisiawati Khalil, Kunal Shah, PMP®, Alvin Ong, and Joyce Lim. Public-private collaboration is crucial for accelerating medical advancements in Singapore. By bringing together the expertise and resources of both sectors, a synergistic approach emerges, enabling faster development and testing of new treatments. This collaboration enhances the efficiency of clinical trials, ensuring a diverse participant pool and comprehensive data collection. Moreover, this partnership strengthens the nation's position as a hub for cutting-edge research, attracting pharmaceutical companies and boosting the local economy. Ultimately, it contributes to the well-being of Singapore's population by expediting the availability of novel therapies and improving healthcare outcomes. #clinicaltrialaccess #publicprivatepartnership #medicaladvancements #innovation #singapore #healthcare #noveltherapies

Beyond longer lifespans, researchers aim to ensure that people enjoy more of those years in good health 👵🏼 In its latest issue, A*STAR Research spotlights the work of A*STAR research institutes and ecosystem partners to bolster the healthspan of Singapore’s ageing residents. “As Singapore itself is set to reach super-aged status as early as 2026, this trend understandably presents significant challenges in healthcare, economics, environment and social dynamics; not just for Singapore, but for the Asian region,” said Sze-Wee TAN, Assistant Chief Executive at A*STAR’s Biomedical Research Council (BMRC). 💡 The country’s vision is grounded in the principle of ‘ageing-in-place’, which enables seniors to live independently within their communities through the support of digital technologies tailored to the unique needs of their age. Grab your copy today by following the link in the comments section! ⬇️ --- #scicomm #science #technology #STEM #research #innovation #ASTAR #aging #health #lifesciences #syntheticbiology #artificialintelligence #Singapore